Healthcare provider profile · identity verified

Rebecca Barton

Nurse Practitioner · LEBANON, VA · NPI 1669650354

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	473	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	342	68
Oxycodone Hcl	Oxycodone Hcl	309	49
Omeprazole	Omeprazole	199	64
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	193	40
Atorvastatin Calcium	Atorvastatin Calcium	172	66
Levothyroxine Sodium	Levothyroxine Sodium	166	55
Lisinopril	Lisinopril	159	63
Amlodipine Besylate	Amlodipine Besylate	157	50
Albuterol Sulfate Hfa	Albuterol Sulfate	133	56
Montelukast Sodium	Montelukast Sodium	121	39
Alprazolam	Alprazolam	107	20
Simvastatin	Simvastatin	105	37
Losartan Potassium	Losartan Potassium	103	44
Hydrochlorothiazide	Hydrochlorothiazide	102	40
Tizanidine Hcl	Tizanidine Hcl	97	26
Tamsulosin Hcl	Tamsulosin Hcl	96	31
Carvedilol	Carvedilol	95	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	26
Fluticasone Propionate	Fluticasone Propionate	83	28
Ondansetron Hcl	Ondansetron Hcl	79	21
Trazodone Hcl	Trazodone Hcl	79	29
Rosuvastatin Calcium	Rosuvastatin Calcium	78	26
Clonazepam	Clonazepam	76	16
Pantoprazole Sodium	Pantoprazole Sodium	76	34
Alendronate Sodium	Alendronate Sodium	74	20
Prednisone	Prednisone	73	33
Metformin Hcl	Metformin Hcl	69	28
Ibuprofen	Ibuprofen	68	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	65	19
Escitalopram Oxalate	Escitalopram Oxalate	64	20
Meloxicam	Meloxicam	62	22
Testosterone Cypionate	Testosterone Cypionate	62	12
Trulicity	Dulaglutide	59	13
Duloxetine Hcl	Duloxetine Hcl	56	19
Hydroxyzine Hcl	Hydroxyzine Hcl	55	19
Furosemide	Furosemide	51	21
Glipizide	Glipizide	50	17
Methylprednisolone	Methylprednisolone	50	38
Ondansetron Odt	Ondansetron	50	18
Buspirone Hcl	Buspirone Hcl	49	16
Ezetimibe	Ezetimibe	49	15
Famotidine	Famotidine	49	17
Metoprolol Tartrate	Metoprolol Tartrate	46	19
Azithromycin	Azithromycin	43	37
Pregabalin	Pregabalin	43	suppressed
Potassium Chloride	Potassium Chloride	42	19
Ozempic	Semaglutide	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	23
Mirtazapine	Mirtazapine	38	13
Symbicort	Budesonide/Formoterol Fumarate	38	12
Clonidine Hcl	Clonidine Hcl	37	12
Clopidogrel	Clopidogrel Bisulfate	37	12
Metoprolol Succinate	Metoprolol Succinate	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	13
Sucralfate	Sucralfate	33	suppressed
Eliquis	Apixaban	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	14
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	13
Atenolol	Atenolol	30	15
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Baclofen	Baclofen	24	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Amoxicillin	Amoxicillin	21	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Valsartan	Valsartan	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Finasteride	Finasteride	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Colchicine	Colchicine	17	suppressed
Topiramate	Topiramate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Fluconazole	Fluconazole	15	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Diazepam	Diazepam	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error